BioMarin’s Voxzogo Predicted For Blockbuster Sales, But Market Must Be Built

 
• By Joseph Haas

Very early launch numbers look good in France and Germany, but US launch will be more challenging due to a fragmented patient base, the company said. Launch price is a flat $899 per vial.

Rocket takes off from the hand of the businessman. Concept of start up.
BioMarin knows US launch of Voxzogo will be an arduous process

More from New Products

More from Scrip